This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: The State University of New York. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2023
Title: Jennifer Schneider: Innovator in Immune Tolerance Induction
Introduction
Jennifer Schneider is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of immune tolerance induction, holding a total of 3 patents. Her work focuses on innovative compositions and methods that enhance the body's ability to tolerate proteins.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Phosphoserine containing compositions for immune tolerance induction." This patent discloses compositions and methods for inducing immune tolerance to proteins, which includes the subsequent administration of these proteins. The compositions comprise proteins complexed with liposomes that contain phosphoserine (PS) and phosphatidylcholine (PC), wherein at least part of the PS is present as lyso-phosphoserine (lyso-PS). This innovative approach has the potential to transform therapeutic strategies in immunology.
Career Highlights
Jennifer Schneider is affiliated with the State University of New York, where she continues to advance her research in immune tolerance. Her academic and professional journey has been marked by a commitment to exploring the complexities of immune responses and developing novel solutions.
Collaborations
Throughout her career, Jennifer has collaborated with esteemed colleagues, including Sathy Balu-Iyer and Richard Bankert. These partnerships have enriched her research and contributed to the advancement of her innovative projects.
Conclusion
Jennifer Schneider stands out as a leading inventor in the field of immune tolerance induction. Her contributions, particularly in the development of phosphoserine-containing compositions, highlight her dedication to advancing medical science. Her work not only showcases her innovative spirit but also promises to impact the future of immunological therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile